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Abstract
Introduction: The capacity of bone marrow mesenchymal stromal cells (BMSCs) to be induced into chondrocytes has
drawn much attention for cell-based cartilage repair. BMSCs represent a small proportion of cells of the bone marrow
stromal compartment and, thus, culture expansion is a necessity for therapeutic use. However, there is no consensus on
how BMSCs should be isolated nor expanded to maximize their chondrogenic potential. During embryonic
development pluripotent stem cells differentiate into chondrocytes and form cartilage in a hypoxic microenvironment.
Methods: Freshly harvested human BMSCs were isolated and expanded from the aspirates of six donors, under
either hypoxic conditions (3% O2) or normoxic conditions (21% O2). A colony-forming unit fibroblastic (Cfu-f) assay
was used to determine the number of cell colonies developed from each donor. BMSCs at passage 2 (P2) were
characterized by flow cytometry for the phenotypic expression of cell surface markers on mesenchymal stem cells.
BMSCs at P2 were subsequently cultured in vitro as three-dimensional cell pellets in a defined serum-free
chondrogenic medium under normoxic and hypoxic conditions. Chondrogenic differentiation of the BMSCs was
characterized by biochemical and histological methods and by quantitative gene-expression analysis.
Results: After 14 days of culture, the number of BMSC colonies developed under hypoxia was generally higher (8%
to 38% depending on donor) than under normoxia. BMSCs were positive for the cell surface markers CD13, CD29,
CD44, CD73, CD90, CD105 and CD151, and negative for CD34. Regardless of the oxygen tension during pellet
culture, hypoxia-expanded BMSC pellets underwent a more robust chondrogenesis than normoxia-expanded BMSC
pellets after three weeks of culture, as judged by increased glycosaminoglycan synthesis and Safranin O staining,
along with increased mRNA expression of aggrecan, collagen II and Sox9. Hypoxic conditions enhanced the mRNA
expression of hypoxia inducible factor-2 alpha (HIF-2a) but suppressed the mRNA expression of collagen X in
BMSC pellet cultures regardless of the oxygen tension during BMSC isolation and propagation.
Conclusions: Taken together, our data demonstrate that isolation and expansion of BMSCs under hypoxic
conditions augments the chondrogenic potential of BMSCs. This suggests that hypoxia-mediated isolation and
expansion of BMSCs may improve clinical applications of BMSCs for cartilage repair.
Keywords: Chondrogenesis, chondrocytes, hypoxia, bone marrow stem cells, tissue engineering, cartilage repair
Introduction
Articular cartilage covers the end of long bones in
articulating joints where it provides near frictionless
movement. Unfortunately, articular cartilage has a very
limited capacity to repair after injury. If left untreated,
cartilage defects progressively lead to more extensive
lesions and, ultimately, require joint arthroplasty. Cell-
based strategies using culture expanded autologous
chondrocytes from non-loading regions of articular car-
tilage are currently used to treat focal cartilage defects
[1]. However, there is some evidence of progressive
degenerative changes in the joint using this technique
[2]. Furthermore, there is evidence that the matrix-form-
ing capacity of expanded chondrocytes is compromised* Correspondence: adesida@ualberta.ca
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due to de-differentiation processes [3,4]. Thus, there is
interest in other cell sources for cartilage repair.
Adherent bone marrow stromal cells or bone marrow
mesenchymal stromal cells (BMSCs) have received
much interest for cartilage repair because of their multi-
potent capacity to differentiate into different cell types
including chondrocytes [5-10]. While there has been
much study related to the potential of BMSCs to form
cartilaginous tissue, there has been a limited number of
reports of the implantation of human BMSCs for carti-
lage repair [11]. The reason for this is unclear but may
be related to hypertrophic differentiation or the lack of
a consensus on how human BMSCs are to be cultured
for reproducible and optimal chondrogenic differentia-
tion. Human BMSCs have been estimated to account
for a mere 0.001% to 0.01% of the total bone marrow
mononuclear cells (MNCs) in the stromal compartment
of bone marrow [5,12,13]. Thus, in vitro culture expan-
sion is a requisite for increasing cell numbers for
research and clinical applications. Since the first pub-
lished report of Friedenstein and co-workers [14],
describing the isolation and expansion of an adherent
and spindle-shaped population of cells from whole
human bone marrow aspirates, little has changed in the
methodology of isolation and expansion of BMSCs.
While it is practiced within the art that human BMSCs
are isolated after initial cell adherence to tissue culture
plastic ware and subsequent cell expansion under nor-
mal mammalian conditions of air containing 21% oxy-
gen tension (normoxia), there is increasing evidence that
BMSCs are adapted to limiting metabolic conditions
[15]. In agreement with this observation, hypoxic (3%
O2) conditions have been reported to favor the multi-
potentiality of a subpopulation of human bone marrow
stromal cells over osteogenic differentiation [16].
Accordingly, human BMSCs showed enhanced prolifera-
tive activity under hypoxic (1.5% to 3% O2) conditions
relative to normoxia [16-18]. While these studies
demonstrated the effect of hypoxia on human BMSC
expansion in vitro, the downstream effect of hypoxic
conditions during isolation and expansion on human
BMSCs’ chondrogenic differentiation capacity was unex-
plored. D’Ippolito et al. [16] and Grayson et al. [18]
investigated osteogenic differentiation of BMSCs after
hypoxia mediated expansion, while the study of Martin-
Rendon et al. [17] investigated chondrogenesis on com-
mercially acquired human BMSCs that lacked initial iso-
lation and cell expansion culture history prior to further
cell propagation under normoxia and subsequent chon-
drogenic differentiation under normoxia and hypoxia for
their studies; hypoxia enhanced BMSC chondrogenic
differentiation potential.
Ovine BMSCs have been isolated and propagated
under hypoxia (5% O2) and shown to increase in
proliferation rate relative to cells expanded under nor-
moxia. Moreover, it was demonstrated that ovine
BMSCs isolated and expanded under hypoxic conditions
and subsequent chondrogenic differentiation under nor-
moxia displayed an enhanced chondrogenic phenotype
compared to their counterparts after normoxia mediated
isolation and expansion [19]. However, it is not clear
whether hypoxia isolated and propagated ovine BMSCs
would have similarly displayed improved chondrogenesis
had they been differentiated under hypoxic conditions.
While it has been shown that normoxia isolated and
expanded non-human and human BMSCs undergo
enhanced chondrogenic differentiation under hypoxic
conditions [9,17,20], it is unknown whether human
BMSCs isolated and expanded under hypoxia are predis-
posed towards improved subsequent chondrogenesis
regardless of the oxygen tension. The study of Mueller
et al. [20], showed that hypoxic conditions during
expansion culture of human BMSCs resulted in
improved chondrogenesis even under normoxic condi-
tions. However, the study used BMSCs that had been
initially isolated and expanded under normoxia prior to
further culture expansion under hypoxia and subsequent
chondrogenic differentiation culture under hypoxia and
normoxia. Perhaps the improved chondrogenesis noted
by Mueller et al. was not surprising because, during
embryonic development, cartilage formation occurs
when mesenchymal stem cells condense and differenti-
ate into chondrocytes during an avascular period in a
low oxygen tension microenvironment [21]. Thus, oxy-
gen tension is known to play a significant role in the
fate of mesenchymal stem cells.
In this study, we investigated the effect of oxygen ten-
sion from the onset of human BMSCs isolation and
expansion on subsequent in vitro chondrogenesis under
normoxic and hypoxic conditions. We hypothesized that
persistent hypoxic culture during human BMSC isola-
tion and expansion enhances the chondrogenic differen-
tiation capacity under normoxia and hypoxia by altering
the expression of genes that facilitate chondrogenesis.
Typically, in vitro chondrogenesis of BMSCs is per-
formed in 3D cell pellet culture, in order to mimic
mesenchymal cell condensation during chondrogenesis
in embryonic development, in the presence of serum
free chondrogenic factors comprising TGF-b1 or -b3,
dexamethasone, ascorbate and ITS+1 under normoxic
conditions [6,9,10,19,22-25]. In this study, we adopted
the pellet culture method to investigate in vitro chon-
drogenesis of both normoxia and hypoxia isolated and
expanded human BMSCs. In vitro chondrogenesis was
implemented under normoxic conditions only, in order
to isolate the downstream effect of cell isolation and
expansion under hypoxic conditions on BMSC chondro-
genesis; several studies have reported that hypoxic
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culture conditions enhance chondrogenic differentiation
[9,20,26-32].
Materials and methods
Collection of bone marrow specimens and culture bone
marrow stem cells
Bone marrow aspirates were obtained from surgically
discarded material after approval and a waiver of
informed consent of the local ethical committee of the
University of Alberta (Edmonton, Canada) during ortho-
pedic procedures from the iliac crest of six donors
(Table 1; one woman, 34 years old, and five men, 43 to
62 years old). The number of nucleated cells in the aspi-
rates was determined by crystal violet nuclei staining
and cell counting using a hemacytometer. Thereafter, 15
million mono-nucleated cells (MNCs) were seeded per
150 cm2 tissue culture flask. The culture medium was
aMEM supplemented with 10% heat inactivated fetal
bovine serum, penicillin-streptomycin, 4-(2-hydro-
xyethyl)-1-piperazineethanesulfonic acid (HEPES),
sodium pyruvate (all from Invitrogen, Mississauga,
Ontario, Canada) and 5 ng/ml basic fibroblast growth
factor (bFGF or FGF2; from Humanzyme, Medicorp
Inc., Montreal, Quebec, Canada) in order to maintain
pluri-potency [33]. Nucleated cells were allowed to
adhere and grow for seven days before the first media
change under normoxia (ambient oxygen tension of
21%) or hypoxia (low oxygen tension of 3% O2) at 37°C
in a humidified incubator with 5% CO2. Thereafter, the
media were changed twice per week until 70% to 80%
cell confluence was obtained. However, during feeds
hypoxia cultivated cells experienced short periods (< 5
minutes) of re-oxygenation. These adherent bone mar-
row stromal cells (BMSCs) were detached using 0.05%
trypsin-ethylenediaminetetraacetic acid (EDTA) (Sigma-
Aldrich, Oakville, Canada) and expanded under nor-
moxia or hypoxia until passage 2 prior to experimental
use. The time taken from plating of nucleated cells (P0)
to reach approximately 80% confluence at passage 2,
before experimental use, varied three to four weeks and
was donor and oxygen tension dependent. Both nor-
moxia- and hypoxia-expanded BMSCs from the same
donor were kept in culture for the same duration until
experiments. The experimental set up for BMSC isola-
tion, expansion and subsequent chondrogenic differen-
tiation is illustrated in Figure 1.
Colony forming unit fibroblastic (cfu-f) assay
The proportion of adherent cell population within each
bone marrow aspirate specimen was assessed by Cfu-f
assay. Cfu-f was performed by plating 2.5 × 105
nucleated cells in 100 mm sterile petri dishes in tripli-
cate (Becton Dickinson, Mississauga, Ontario, Canada).
The cells were cultured as described before using
aMEM supplemented with 10% heat inactivated fetal
bovine serum, penicillin-streptomycin, HEPES, sodium
pyruvate and 5 ng/ml FGF-2 for two weeks under nor-
moxia or hypoxia. After the first week, the non-adherent
cell population was removed by aspiration and culture
media were replenished every three days until two
weeks of culture. During feeds, hypoxia cultivated cells
experienced a short period (< 5 minutes) of exposure to
normal oxygen tension. After two weeks the developed
cell colonies were visualized after fixing with 4% phos-
phate buffered formalin, washing by PBS and staining
using 0.25% crystal violet solution (Sigma-Aldrich). The
number of cell colonies developed was recorded as well
as their respective diameters. Data were compared in a
Student t-test and a significant difference between the
two culture conditions was considered when P < 0.05.
Flow cytometry analysis
All primary monoclonal antibodies used herein were
directly conjugated antibodies to fluorescein isothiocya-
nate (mAb-FITC) or to phycoerythrin (mAb-PE). Anti-
bodies were either from BD Pharmingen or Invitrogen-
see Table 2. The cells were analyzed on a FACScan flow
Table 1 Donor information of bone marrow aspirates








Figure 1 Experimental set up for isolation, expansion and in
vitro chondrogenesis of bone marrow mesenchymal stromal
cells (BMSCs).
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cytometer (Becton Dickinson) after detachment from
the culture flask by 0.05% w/v trypsin-EDTA (Sigma).
Staining buffer was prepared with PBS containing 1% w/
v BSA (Sigma). Normoxia and hypoxia expanded
BMSCs were re-suspended in 4°C cold staining buffer at
5 × 106/ml. The cells were dispensed into sample tubes
(12 × 75 mm polystyrene round-bottom tubes, Becton
Dickinson) in 20 μl aliquots and incubated for 15 min-
utes with the antibodies at 4°C. All incubations were
implemented in 5 ml dilution tubes at room tempera-
ture in the dark and all washing steps were performed
by a combination of centrifugation (400 g, 5 minutes)
and aspiration of supernatant. Staining buffer (200 μl)
was then added to the tubes and the cells were incu-
bated for 10 additional minutes. After removal of the
supernatant by centrifugation, cells were washed with
PBS and kept cold before analysis by flow cytometry.
Non-specific staining was assessed using relevant isotype
controls. Single color immunofluorescence analysis for
the different surface markers was performed with mAb-
FITC and mAb-PE. Data acquisition was performed
with Cellquest software (Becton Dickinson). FITC emis-
sion was measured at FL1 and PE at FL3. For each sam-
ple a region for live cells was defined, according to the
Forward Scatter (FSC) and Side Scatter (SSC) signals,
which excluded aggregated cells from the analysis. Data
analysis was performed with Cyflogic version 1.2.1,
Perthu Terho &©CyFlo Ltd., Finland. For each surface
marker analyzed, the percentage of positive cells and the
level of marker expression were calculated. The percen-
tage of positive cells was calculated as the percentage of
cells having a measured fluorescence greater than that
of 99.5% of the cells stained with each associated isotype
control. Cells were considered positive for a surface
marker when the percentage of positive cells for that
surface marker was ≥ 6%. The level of expression of
each marker was calculated as the ratio between geo-
metric mean fluorescence intensity (MFI) of samples
and that of the isotype control.
In vitro chondrogenic differentiation
BMSCs at passage 2 (P2) were re-suspended in chon-
drogenic culture medium consisting of high glucose (D)
MEM containing 4.5 mg/ml D-Glucose, 0.1 mM non-
essential amino acids, 1 mM sodium pyruvate, 100 mM
HEPES buffer, 1 mM sodium pyruvate, 100 U/ml peni-
cillin, 100 μg/ml streptomycin, 0.29 mg/ml L-glutamine
(all from Invitrogen) supplemented with 0.1 mM ascor-
bic acid 2-phosphate, 10-5 M dexamethasone, 1x ITS+1
premix (Sigma-Aldrich), and 10 ng/ml TGFb1 (Human-
zyme-Medicorp Inc.). For chondrogenesis in pellet cul-
ture, a total of 2.5 × 105 cells were spun in 1.5 ml
sterile conical polypropylene microfuge tubes (Enzymax
LLC, Kentucky, USA) at 1500 rpm for three minutes to
form spherical cell pellets. The final volume of chondro-
genic media was 250 μl per pellet. Medium change was
performed three times a week. Hypoxia cultivated pellets
experienced a short period (< 5 minutes) of exposure to
normal oxygen tension during media changes. The pel-
lets were cultured for three weeks under normal or low
oxygen tension to allow appreciable matrix accumula-
tion. Thereafter, the pellets were processed biochemi-
cally for glycosaminoglycan (GAG) and DNA contents,
histologically, immunohistochemically and gene expres-
sion analysis via quantitative reverse transcription poly-
merase chain reaction (qRT-PCR) for cartilage specific
matrix gene and proteins expression.
Biochemical analysis
In vitro cultivated pellets were rinsed in PBS (Invitro-
gen) and were digested in proteinase K (1 mg/ml in 50
mM Tris with 1 mM EDTA, 1 mM iodoacetamide and
Table 2 Antibodies used to characterize normoxia and hypoxia expanded BMSC
Specificity Isotypea Cat.#/Flurochrome Source
CD13 (aminopeptidase-n) mIgG1 sc-70529/PE Santa Cruz Biotechnology
CD29 mIgG1 CD2901/FITC Invitrogen
CD34 mIgG1 sc-19621/FITC Santa Cruz Biotechnology
CD44 (Pgp-1, H-CAM, Ly 24) mIgG2b 560977/FITC BD Pharmingen
CD73 mIgG1 550257/PE BD Pharmingen
CD90 (Thy-1) mIgG1 55596/PE BD Pharmingen
CD 105 (endoglin) mIgG1 sc-71043/PE Santa Cruz Biotechnology
CD151 (PETA-3) mIgG1 556057/PE BD Pharmingen
Not specified (Isotype control) mIgG1 sc-2855/FITC Santa Cruz Biotechnology
Not specified (Isotype control) mIgG1 sc-2866/PE Santa Cruz Biotechnology
Not specified (Isotype control) mIgG2b sc-2857/FITC Santa Cruz Biotechnology
Mouse pooled immunoglobulin (Isotype control) rIgG2a 554688/FITC BD Pharmingen
TNP-KHL (Isotype control) mIgG2a 555575/PE-Cy™5 BD Pharmingen
am, mouse; r, rat. BMSC, bone marrow mesenchymal stromal cells; CAT.#, catalogue number.
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10 mg/ml pepstatin A; all from Sigma-Aldrich) for 16
hours at 56°C. The sulfated GAG content was measured
by 1,9-dimethymethylene blue binding (Sigma-Aldrich)
using chondroitin sulfate (Sigma-Aldrich) as standard.
The DNA content was determined using the CyQuant
cell proliferation assay kit (Invitrogen) with supplied
bacteriophage l DNA as standard. Statistical differences
between test groups were evaluated by one-way analysis
of variance (ANOVA) with Tukey’s multiple comparison
post-tests. Statistical analyses were performed using
SPSS (version 18). A significant difference was consid-
ered when P < 0.05.
Histology and immunohistochemistry
Tissues generated from the pellet cultures were fixed in
4% phosphate buffered formalin, processed into paraffin
wax, sectioned at 5 μm and stained with 0.1% safranin
O and counterstained with 1% fast green to reveal sul-
fated proteoglycan (GAG) matrix depositions. Other sec-
tions were probed with antibodies raised against
collagen types I and II. Sections were treated with tryp-
sin and then incubated with antibodies against collagen
I (MAB3391, Millipore, Temecula, California, USA) or
collagen II (II-II6B3 from Developmental Studies Hybri-
doma Bank at University of Iowa, USA). Immuno-loca-
lized antigens were visualized with goat anti-mouse IgG
biotinylated secondary antibody (Dako Canada Inc, Mis-
sissauga, Ontario, Canada) and a streptavidin-horserad-
ish peroxidase labeling kit with 3,3’-diaminobenzidine
(Dako). Images were captured using an Omano
OM159T biological trinocular microscope (Microscope
Store, Virginia, USA) fitted with an Optixcam summit
series 5MP digital camera and Optixcam software and
assembled in Adobe Photoshop (Adobe Systems Inc.
San Jose, USA).
Gene expression analysis
Total RNA was extracted from pellets using Tri-Reagent
(Sigma-Aldrich) after grinding with Molecular Grinding
Resin (Geno Technology Inc. St Louis, USA) in combi-
nation with the use of an Aurum Total RNA Fatty and
Fibrous Tissue Kit (Bio-Rad, Mississauga, Ontario,
Canada) and after removal of contaminating genomic
DNA from the pellets by DNase treatment. In order to
mitigate changes in gene expression, the caps of pellet
cultures were closed before removal from the low oxy-
gen tension incubator and cell pellets were immediately
transferred into Tri-Reagent. Total RNA (100 ng) in a
40 μl reaction was reverse transcribed to cDNA using
GoScript reverse transcriptase (Fisher Scientific, Whitby,
Ontario, Canada) primed in the presence of oligo dT
primers (1 μg). Real-time quantitative polymerase chain
reaction (qRT-PCR) was performed with a DNA Engine
Opticon II Continuous Fluorescence Detection System
(Bio-Rad) using hot start Taq and SYBR Green detec-
tion (Eurogentec North America Inc, San Diego, CA,
USA). Primer sequences (Table 3) were taken from pre-
viously published work or were custom designed using
the Primer Express software (Applied Biosystems, Foster
City, California, USA) [23,34,35]. All primers were
obtained from Invitrogen. Gene (mRNA) expression
levels for each primer set were normalized to the
expression level of human b-actin [9,34,36] by the 2-Δct
method [37]. Statistical differences between test groups
were evaluated by one-way ANOVA with Tukey’s multi-
ple comparison post-tests. Statistical analyses were per-
formed using SPSS (version 18). A significant difference
was considered when P < 0.05.
Ethical considerations
All studies were implemented with stem cells propa-
gated from bone marrow aspirates taken from surgical
discards of patients undergoing routine orthopedic pro-
cedures after approval and a waiver of informed consent
of the local ethical committee of the University of
Alberta (Edmonton, Canada).
Results
Effect of oxygen tension on the colony forming
characteristics
To investigate the colony forming characteristics of
adherent BMSCs cultured under normoxia and hypoxia,
the number and diameter of the cell colonies developed
after 14 days of culture of bone marrow MNCs was
evaluated (Figure 2). The number of adherent cell colo-
nies developed was consistently higher under hypoxic
conditions by 8% to 37% albeit with dependence on the
donor (BM68 (13%), BM69 (9%), BM73 (14%), BM74
(37%), BM79 (8%) and BM84 (23%)) (Figure 2b). There
was no significant difference between the measured dia-
meters of the cell colonies under normoxia and hypoxia
(Figure 2c).
Effect of oxygen tension on the expression of cell surface
markers
To investigate the immuno-phenotype of the adherent
population of BMSCs isolated and expanded under nor-
moxia and hypoxia, we analyzed the cell surface mole-
cule expression from three different donors: BM68,
BM73 and BM84. A panel of cell surface markers that
are typically used to characterize mesenchymal stem
cells was selected [25,38]. Both normoxia and hypoxia
expanded BMSCs were positive for CD13, CD29, CD44,
CD73, CD90, CD105 and CD151. Both normoxia and
hypoxia expanded BMSCs were negative for CD34. The
positive cell surface markers expressed on the adherent
BMSCs displayed a single fluorescence peak binding
profile by flow cytometry (Figure 3a). However,
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quantitative expression levels (MFI) of cell surface mar-
kers were dependent on donors and on the oxygen ten-
sion during cell expansion. For example, the expression
level of CD90 was consistently and significantly lowered
in hypoxia-expanded BMSCs compared to normoxia-
expanded BMSCs (Figures 3b, c, d and 3e).
Downstream effect of oxygen tension on extracellular
matrix formation
Safranin-O staining for sulfated GAG matrix deposition
of pellets derived from four donors (BM68, BM73,
BM74 and BM84) showed that the pellets derived from
hypoxia-expanded BMSCs stained more strongly and
more uniformly throughout the pellet than their coun-
terparts from normoxia-expanded BMSCs, albeit with
dependence on the donor (Figure 4). Furthermore, most
pellets derived from normoxia-expanded BMSCs
increased in safranin O staining under hypoxia, while
pellets derived from hypoxia-expanded BMSCs remained
intensely stained with safranin O. Quantitative GAG
matrix normalized to DNA content of the pellets was
determined (Figures 4e, j, o and 4t). The pellets formed
from hypoxia-expanded BMSCs had a 1.4 to 3.5 fold
increased GAG per DNA content than their counter-
parts from normoxia-mediated expansion, depending on
the donor, when pellets were cultivated under normoxia
while the pellets derived from hypoxia-expanded BMSCs
had a 1.2 to 7.0 fold enhancement in GAG per DNA
content than pellets from normoxia-expanded BMSCs
when cultured under hypoxic conditions. These results
correlated with the more uniform and intense safranin
O staining observations in the pellets derived from
hypoxia cultivated BMSCs. In the pooled data set, the
mean GAG per DNA content of the pellets from
hypoxia-expanded BMSCs was 1.7-fold (P < 0.05) higher
than their normoxia counterparts under normoxic con-
dition while under hypoxic condition. There was a lin-
ear-inverse relationship between the GAG per DNA
contents of pellets and age of BMSC donors under a
specific culture condition (data not shown).
Downstream effect of oxygen tension on chondrogenic
gene and protein expression, and TGFb receptor
expression
Quantitative RT-PCR was performed for gene expres-
sion analysis on pellets derived from four donors
(BM68, BM73, BM74 and BM84) after three weeks of
chondrogenic culture. The mean relative gene expres-
sion of aggrecan (AGG), collagen I (Col1a2), collagen II
(Col2a1), collagen X (Col10a1), cartilage oligomeric
matrix protein (COMP), HIF-1a and HIF-2a, Sox9,
TGFb1-receptor I (TGFb1-RI) and TGFb1-receptor II
Table 3 Primer sequences used in quantitative real-time PCR (all primers were purchased from Invitrogen,
Mississauga, Ontario, Canada)
Primer Reference
b-Actin 5’-AAGCCACCCCACTTCTCTCTAA-3’ (Forward) [34]
5’-AATGCTATCACCTCCCCTGTGT-3’ (Reverse)
Aggrecan 5’-AGGGCGAGTGGAATGATGTT-3’ (Forward) [34]
5’-GGTGGCTGTGCCCTTTTTAC-3’ (Reverse)
Collagen 1A2 5’-TTGCCCAAAGTTGTCCTCTTCT-3’ (Forward) [34]
5’-AGCTTCTGTGGAACCATGGAA-3’ (Reverse)
Collagen 2A1 5’-CTGCAAAATAAAATCTCGGTGTTCT-3’ (Forward) [34]
5’-GGGCATTTGACTCACACCAGT-3’ (Reverse)
Collagen 10A1 5’-CTGCAAAATAAAATCTCGGTGTTCT-3’ (Forward) [23]
5’-GGGCATTTGACTCACACCAGT-3’ (Reverse)
COMP 5’-CCGACAGCAACGTGGTCTT-3’ (Forward) [23]
5’-CAGGTTGGCCCAGATGATG-3’ (Reverse)
HIF-1a 5’-GTAGTTGTGGAAGTTTATGCTAATATTGTGT-3’ (Forward) [35]
5’-CTTGTTTACAGTCTGCTCAAAATATCTT-3’ (Reverse)
HIF-2a 5’-GGTGGCAGAACTTGAAGGGTTA-3’ (Forward) [30]
5’-GGGCAACACACACAGGAAATC-3’ (Reverse)
SOX9 5’-CTTTGGTTTGTGTTCGTGTTTTG-3’ (Forward) [34]
5’-AGAGAAAGAAAAAGGGAAAGGTAAGTTT-3’ (Reverse)
TGFb-RI 5’-GGCTTTTCTCCACATGCTTAGG-3’ (Forward) [39]
5’-GGCAACAGAGATCACCTGTAGACA-3’ (Reverse)
TGFb-RII 5’-CAGTGTGGCTGCAGTAGCATAGA-3’ (Forward) [39]
5’-CATGCCCTACGGTGCAAGT-3’ (Reverse)
PCR, polymerase chain reaction.
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(TGFb1-RII) in the pooled pellets is presented in Figures
5 and 6. The mRNA expression levels of Col2a1 (2.44-
fold) and Sox9 (2-fold) were significantly higher in pel-
lets formulated from hypoxia-expanded BMSCs than in
pellets derived from normoxia-expanded BMSCs after
culture under normoxic conditions (Figure 5). The
mean mRNA expression of AGG was not significantly
higher in the pellets derived from hypoxia isolated and
expanded BMSCs under normoxic conditions when
compared to those derived from normoxia-expanded
BMSCs (Figure 5). Under hypoxic culture condition, the
mean mRNA expression level of AGG and Col2a1 were
2-fold higher while the mRNA expression of Sox9 was
3-fold higher in pellets derived from hypoxia-expanded
BMSCs compared to their counterparts from normoxia-
expanded BMSCs (Figure 5). The mean mRNA expres-
sion level of Col1a2 was significantly higher in pellets
formulated from normoxia expanded BMSCs after cul-
ture under normoxic conditions while the expression of
Col10a1 and COMP were not significantly different
between the pellets from normoxia- and hypoxia-
expanded BMSCs (Figure 5). In contrast, under hypoxic
conditions of pellet culture the expression of Col1a2,
regardless of the oxygen tension during BMSC expan-
sion, was not significantly different between pellets (Fig-
ure 5). The expression of COMP increased under
hypoxic pellet culture conditions relative to expression
in pellets cultivated undr normoxia. However, the incre-
ment was not stastically significant. Col10a1 decreased
significantly under hypoxic conditions of pellet culture.
Figure 3 Flow cytometry analysis of cell surface markers on
passaged 2 (P2) BMSCs after culture in a-MEM comprising
10% FBS and 5 ng/ml FGF-2. (A) Representative fluorescence
intensity histograms are presented showing expression of cell
surface markers of normoxia- and hypoxia-expanded BMSCs at P2 of
a 43-year-old man (BM74). (B-D) The mean fluorescence intensity
(MFI) of cell surface markers on BMSCs from: (B) a 34-year old
woman (BM68), (C) a 43-year-old man (BM74), (D) a 62-year-old man
(BM84). (E) Represents the mean fluorescence intensity ± standard
error of three donors; BM68, BM74 and BM84. *P < 0.05 in normoxia
versus hypoxia, Student’s t test. BMSCs, bone marrow mesenchymal
stromal cells; FBS, fetal bovine serum; FGF-2, fibroblast growth
factor-2; MEM, modified Eagle’s medium.
Figure 2 (A) Representative photograph of colony forming unit
fibroblastic (cfu-f) assay of passage 0 (P0) BMSC after 14 days
of culture under normoxia or hypoxia. Bone marrow mono-
nucleated cells (MNCs) were seeded into 100 mm petri dish in
triplicate (n = 3) at 250,000 MNCs per dish. Culture media was a-
MEM comprising 10% FBS and 5 ng/ml FGF-2. Media were not
changed within the first seven days. Thereafter, the media were
changed twice a week. Developed cell colonies were visualized by
crystal violet staining. (B) The number of cell colonies developed in
the Cfu-f assay as described in A. The data represent mean ±
standard error of colony counts derived from six donors (n = 3). (C)
The mean diameter of cell colonies developed in the Cfu-f assay as
described in A. The data represents mean ± standard error of
colony counts derived from six donor specimens. Not significant (n.
s.) = P > 0.05 or * P < 0.05 in normoxia versus hypoxia, Student’s t
test. BMSCs, bone marrow mesenchymal stromal cells; FBS, fetal
bovine serum; FGF-2, fibroblast growth factor-2; MEM, modified
Eagle’s medium.
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Col10a1 expression declined by 2225-fold in pellets
formed from normoxia-expanded BMSCs and by 43-fold
in pellets derived from hypoxia-expanded BMSCs when
compared to their respective expression under normoxic
conditions (Figure 5).
Immunohistochemical staining (brown coloration) of
pellets from the four donors confirmed that the pellets
formulated from normoxia- and hypoxia-expanded
BMSCs expressed types I and II collagens. Representa-
tive photomicrographs of pellets (from donor BM74)
labeled with antibodies to collagen I and II are shown in
Figure 6a-6h. The pellets derived from hypoxia-
expanded BMSCs were strongly and uniformly labelled
with anti-collagen type II (Figures 6f (under normoxia)
and 6h (under hypoxia)). In contrast, the pellets formu-
lated from normoxia-expanded BMSCs labeled only
strongly with anti-collagen type II at the pellet periphery
and weakly in the central core (Figures 6e (under nor-
moxia) and 6 g (under hypoxia)). Collagen type I was
uniformly distributed in all pellets regardless of the oxy-
gen tension during pellet culture or whether the pellets
were formed from normoxia or hypoxia-expanded
BMSCs (Figure 6a-6d). Primary antibody and non-speci-
fic IgG controls showed no false positive staining (data
not included).
Figure 5 (A) Real-time PCR analysis of cDNA derived from
pellet cultures of normoxia- and hypoxia-expanded BMSCs.
Pellet cultures were performed under normoxic or hypoxic
conditions for three weeks in the presence of defined serum-free
chondrogenic factors as described Materials and Methods text. Real-
time PCR analysis was via SYBR Green detection. Presented data
represent the mean ± standard error of pellets pooled from four
donors (that is, BM68, BM73, BM74 and BM84) in triplicate (N = 4, n
= 12 per experimental group). Data represent mean ± standard
error of triplicate pellets per donor; one-way ANOVA with Tukey’s
post hoc test: n.s. (not significant), * = P < 0.05, ** = P < 0.001 and
*** = P < 0.0001. Gene expression is presented as relative mRNA
level normalized to mRNA expression of human b-actin; y-axis.
ANOVA, analysis of variance; BMSCs, bone marrow mesenchymal
stromal cells; PCR, polymerase chain reaction.
Figure 4 Paraffin wax 5 μm-section pellets were stained with
safranin-O/fast green stain. All photomicrographs represent low
(4x objectives) images. (A-D) 34-year-old woman (BM68), (F-I) 51-
year-old man (BM73), (K-N) 43-year-old man (BM74) and (P-S) 62-
year-old man (BM84). Scale bar is 100 μm. Biochemical assay of
pellets for sulfated glycosaminoglycan (GAG) per DNA content.
Pellets were cultured for three weeks in a defined serum-free
chondrogenic medium under low (3%) or normal (21% O2) oxygen
tension. Data are mean ± standard error of triplicates. (E) 34-year
old woman (BM68), (J) 51-year-old man (BM73), (O) 43-year-old man
(BM74) and (T) 62-year-old man (BM84). Data represent mean ±
standard error of triplicate pellets; one-way ANOVA with Tukey’s
post hoc test: n.s. (not significant), * = P < 0.05, ** = P < 0.001 and
*** = P < 0.0001. ANOVA, analysis of variance.
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Differential expression of TGFb receptor proteins
TGFb-RI and TGFb-RII have been implicated in the
reduced chondrogenic potential of adipose derived
mesenchymal stem cells under standard chondrogenic
culture conditions using TGF-b1 or TGF-b3 [39]. We
therefore investigated the expression of these receptor
proteins in our pellets. The mRNA expression of TGFb-
RI and TGFb-RII were statistically similar between the
pellets derived from normoxia- and hypoxia-expanded
BMSCs under normoxic conditions. However, under
hypoxic conditions the expression of TGFb-RI in pellets
derived from hypoxia-expanded BMSCs were signifi-
cantly up-regulated by 3.5-fold relative to its expression
in pellets formed from normoxia-expanded BMSCs.
Similarly, the mRNA expression of TGFb-RII was
increased under hypoxic condition in pellets derived
from hypoxia-expanded BMSCs; however, the increment
was not statistically significant relative to its expression
in pellets formed from normoxia-expanded BMSCs (Fig-
ure 6i).
The cellular response to low oxygen tension in many
mammalian cells is regulated by the transcriptional
activity of HIF-1, a heterodimer of HIF-1a and HIF-1b
[40]. HIF-2, a heterodimer of HIF-2a and HIF-1b, has
also been identified as a regulator of the response of
mammalian cells to low oxygen tension [41,42]. In addi-
tion, both HIF-1 and HIF-2 have been implicated in
hypoxia-mediated enhancement of chondrogenesis of
mesenchymal cells [29,30,41-43]. Thus, we investigated
the gene expression of HIF-1a and HIF-2a in our study
pellets after cultivation under normoxic and hypoxic
conditions. The mRNA expression level of HIF-1a was
similar in pellets regardless of whether the pellets were
formed from normoxia- or hypoxia-expanded BMSC or
cultivation of pellets under normoxic or hypoxic condi-
tions (Figure 6i). The expression of HIF-2a was the
same in pellets derived from normoxia- and hypoxia-
expanded BMSCs under normal oxygen tension. How-
ever, under low oxygen tension the expression of HIF-
2a increased regardless of whether the pellets were
derived from normoxia- or hypoxia-expanded BMSCs.
The expression of HIF-2a increased significantly by 3.2-
fold in pellets derived from hypoxia-expanded BMSCs
when compared to its expression in pellets under nor-
moxic conditions. In contrast, the increment determined
(1.6-fold) in pellets derived from normoxia-expanded
BMSCs under hypoxic conditions relative to its expres-
sion in the same pellets under normoxic conditions was
not statistically significant (Figure 6i).
Discussion
In this study we have compared the chondrogenic
potential of human BMSCs obtained under low (3%)
and normal (21%) oxygen tension. The BMSCs were iso-
lated via plastic adherence and cell culture mediated
propagation. We have used flow cytometry to character-
ize the cell surface protein expression of the BMSCs
and used an in vitro pellet model of chondrogenesis
with TGF-b1 to investigate their capacity to undergo
chondrogenic differentiation.
Our data showed that the BMSCs obtained after plat-
ing of bone marrow nucleated cells and subsequent cell
culture propagation under low oxygen tension expressed
a panel of conventionally used mesenchymal stem cell
surface markers but with a consistently reduced
Figure 6 (A-H) Immuno-labeling of 5 μm-sections of pellets
with anti-collagen types I and II. All photomicrographs represent
low (4x objectives) images. Pellets were cultured for three weeks in
chondrogenic medium under low (3%) or normal (21% O2) oxygen
tension. Images were taken from pellets derived from BM73. Scale
bar is 100 μm. (I) Real-time PCR analysis of cDNA derived from
pellet cultures of normoxia- and hypoxia-expanded BMSCs. Pellet
cultures were performed under normoxic or hypoxic conditions for
three weeks in the presence of defined serum-free chondrogenic
factors as described in the Materials and Methods text. Real-time
PCR analysis was via SYBR Green detection. Presented data
represent the mean ± standard error of pellets pooled from four
donors (that is, BM68, BM73, BM74 and BM84) in triplicate (N = 4, n
= 12 per experimental group). Data represent mean ± standard
error of triplicate pellets; one-way ANOVA with Tukey’s post hoc
test: n.s. (not significant), * = P < 0.05 and *** = P < 0.0001. Gene
expression is presented as relative mRNA level normalized to mRNA
expression of human b-actin; y-axis. ANOVA, analysis of variance;
BMSCs, bone marrow mesenchymal stromal cells; PCR, polymerase
chain reaction.
Adesida et al. Stem Cell Research & Therapy 2012, 3:9
http://stemcellres.com/content/3/2/9
Page 9 of 12
concentration (that is, reduced mean fluorescence inten-
sity) of CD90. The BMSCs obtained via propagation
under low oxygen tension underwent a more robust
chondrogenesis than their counterparts under normal
oxygen tension albeit with dependence on the donor.
The reduced CD90 expression in the BMSCs harvested
under hypoxia may be associated with improved chon-
drogenesis. A link between CD90 expression and chon-
drogenic potential of BMSCs has not been reported in
the literature. However, the lack of CD90 expression in
in vitro expanded human articular chondrocytes has
been observed with chondrocytes with higher chondro-
genic potential [44]. Thus, there is reason to speculate
on a potential link between its expression and the chon-
drogenic capacity of BMSCs. Furthermore, in vitro
expanded human articular chondrocytes have also been
reported to display plasticity features that are similar to
those of mesenchymal stem cells [45]. Regardless of the
oxygen tension during pellet culture, the BMSCs iso-
lated and propagated under hypoxic conditions dis-
played a superior chondrogenic capacity than their
counterparts from normal oxygen tension. The superior
chondrogenic capacity was characterized by higher GAG
per DNA content, enhanced transcript expression of a
panel of chondrogenic genes (aggrecan, Col2a1 and
Sox9) as well as the intense and uniform distribution of
collagen II and safranin O staining for sulfated proteo-
glycans. Our data mirrors the findings of Tew et al.
[46], that demonstrated that pellets derived from de-dif-
ferentiated and Sox9 transduced articular chondrocytes
displayed a phenotype that was consistent with a more
robust chondrogenic response (increased safranin O
staining and Col2a1 expression) compared to control
pellets formed from non-transduced and de-differen-
tiated articular chondrocytes. Furthermore, our data of
increased mRNA expression of Sox9 and aggrecan sup-
ports previously reported evidence that transcriptional
activity of Sox9 enhances the gene promoter activities of
aggrecan in chondrocytes [46-49]. Transcriptional fac-
tors Sox9, L-Sox5 and Sox6 have been reported to be
essential for regulating the expression of Col2a1 as well
as other genes involved in chondrogenesis [48,50,51].
The chondrogenic capacity of all pellets in our study
improved further under low oxygen tension. The
improvement was characterized by a marginal (that is,
non-statistically significant) increase in transcript
expression of aggrecan, Col2a1 and COMP. Further-
more, and more significantly, the improvement in chon-
drogenic potential under hypoxia was accompanied by a
concomitant suppression in Col10a1 expression, a mar-
ker of hypertrophic chondrogenesis and terminally dif-
ferentiated chondrocytes. This finding is in accordance
with the observation of Hirao et al. that hypoxia (that is,
5% O2) supports commitment of C3HT10T1/2 (a
pluripotent mesenchymal cell line) to chondrogenic dif-
ferentiation rather than osteogenesis through mechan-
isms involving a concomitant down-regulation of
Col10a1 and Runx2 activity via Smad suppression and
histone deactylase 4 activation (HDAC4) [52].
Our results indicate that the response of BMSCs to
hypoxic conditions involves up-regulation of the tran-
scriptional expression of HIF-2a rather than HIF-1a,
which remained unperturbed. This finding was surpris-
ing since hypoxia has been reported to induce chondro-
cyte-specific gene expression (aggrecan, Col2a and
Sox9) in mesenchymal cells (mouse ST2 stromal cells
and C3HT10T1/2) through transcriptional activity of
HIF-1a [53]. Furthermore, HIF-1a, has been implicated
in hypoxia-mediated inhibition of senescence and main-
tenance of human mesenchymal stem cell properties
[43]. Our finding, therefore suggests that the response
of the BMSCs to hypoxia was mediated by the transcrip-
tional activity of HIF-2a. The involvement of HIF-2a
here is in accordance with a report that hypoxia (that is,
5% O2) enhances the expression of several chondrogenic
genes including Col2a1, aggrecan and Sox9 during
chondrogenesis of adipose derived mesenchymal stem
cells [30]. However, in contrast to the hypoxia-mediated
down-regulation of Col10a1 noted in our present study,
hypoxia (5% O2) enhanced the expression of Col10a1
during the chondrogenic differentiation of adipose
derived mesenchymal stem cells [30]. A plausible expla-
nation for the differential outcome may depend on the
difference in oxygen tension or cell type. Nonetheless,
our data opens the perspective of a possible mechanistic
link between the transcriptional activity of HIF-2a and
collagen X expression.
Differential expression of TGFb-receptors
TGFb-RI and TGFb-RII have been implicated in the
reduced chondrogenic potential of adipose derived
mesenchymal stem cells relative to the chondrogenic
potential of BMSCs. Thus, we investigated the expres-
sion of these receptor proteins in our BMSCs pellets.
Our data showed that the expression of these receptors
was generally higher in pellets derived from hypoxia-
expanded BMSCs after culture in hypoxic conditions.
However, it was surprising that the expression of TGFb-
RI was statistically higher in pellets formulated from
hypoxia-expanded BMSCs during pellet culture under
hypoxic conditions.
Conclusions
We have shown that the isolation and expansion of
BMSCs under hypoxic conditions of 3% oxygen tension
increases the propensity of the BMSCs to undergo a
more robust chondrogenesis under normoxic and
hypoxic culture conditions relative to BMSCs isolated
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and propagated under normoxic conditions. Our results
also show that the response of these cells to low oxygen
tension is mediated by HIF-2a. Taken together, our
finding highlights the need to isolate and propagate
BMSCs under hypoxic conditions for improved in vitro
chondrogenesis and for in vivo cartilage repair and/or
regeneration. The outcome of this study suggests that
oxygen tension is an important factor in the determina-
tion of the chondrogenic differentiation fate of adherent
populations of BMSCs.
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